Asthma (Reversible Obstructive Airways Disease): Salmeterol + Fluticasone propionate (Saltrol) is indicated in the regular treatment of asthma (Reversible Obstructive Airways Disease). This may include: Patients on effective maintenance doses of long-acting β agonists and inhaled corticosteroids.
Patients who are symptomatic on current inhaled corticosteroid therapy.
Patients on regular bronchodilator therapy who require inhaled corticosteroids.
Chronic Obstructive Pulmonary Disease (COPD): Salmeterol + Fluticasone propionate (Saltrol) is indicated in the regular treatment of Chronic Obstructive Pulmonary Disease (COPD) including chronic bronchitis and emphysema.
Other Services
Country
Account